SEELOS THERAPEUTICS, INC. — Form D

SEELOS THERAPEUTICS, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-18. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Richard J BermanDirectorTUCSON, AZ
Roberto J CreaDirectorSan Diego, CA
Bassam B DamajDirectorSan Diego, CA
Henry J EsberDirectorNewton, MA
Vivian B LiuDirectorSan Diego, CA
Edward J CoxExecutive OfficerSan Diego, CA
Bassam B DamajExecutive OfficerSan Diego, CA
Henry J EsberExecutive OfficerNewton, MA
Vivian B LiuExecutive OfficerSan Diego, CA
Mark WestgateExecutive OfficerRancho Cordova, CA
Raj MehraDirectorNew York, NY
Raj MehraExecutive OfficerNew York, NY
Brian LianDirectorNew York, NY
Margaret W DalesandroDirectorNew York, NY
Michael W GolembiewskiExecutive OfficerNew York, NY
Richard W PascoeDirectorNew York, NY
Richard W PascoeExecutive OfficerNew York, NY
Margaret J DalesandroDirectorNew York, NY
Daniel J O'ConnorDirectorNew York, NY
Michael J GolembiewskiExecutive OfficerNew York, NY
Kleanthis G XanthopoulosDirectorSan Diego, CA
Judith W DunnDirectorNew York, NY
Paul V MaierDirectorDeer Park, IL
Robin L SmithDirectorSalt Lake City, UT
WENDELL W WIERENGADirectorSAN DIEGO, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2024-07-30D$1.1M
2024-05-31D$2.0M
2024-02-14D$3.6M
2020-09-14D$5.6M
2019-08-30D$4.0M
2017-09-27D$3.7M$3.7M
2016-10-13D$3.7M$3.7M
2010-03-10D$2.5M$2.3M

More